These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9792307)

  • 1. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Bigoni R; Piva N; Minotto C; Agostini P; De Angeli C; Del Senno L; Spanedda R; Castoldi G
    Br J Haematol; 1998 Oct; 103(1):189-97. PubMed ID: 9792307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
    Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
    Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study.
    Ciccone G; Mirabelli D; Levis A; Gavarotti P; Rege-Cambrin G; Davico L; Vineis P
    Cancer Genet Cytogenet; 1993 Jul; 68(2):135-9. PubMed ID: 8353805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure.
    Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR
    Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
    Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
    Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic findings in primary and secondary MDS.
    Heim S
    Leuk Res; 1992; 16(1):43-6. PubMed ID: 1732669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents.
    Cuneo A; Fagioli F; Pazzi I; Tallarico A; Previati R; Piva N; Carli MG; Balboni M; Castoldi G
    Leuk Res; 1992 Aug; 16(8):789-96. PubMed ID: 1528067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of the Clonal Fraction by Fluorescence In Situ Hybridization in Myelodysplastic Syndrome: Comparison With International Working Group Treatment Response Criteria.
    Park JH; Kim M; Kong SY; Yoon SS; Lee DS
    Arch Pathol Lab Med; 2016 Jun; 140(6):560-9. PubMed ID: 27232348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
    Gmidène A; Sennana H; Fenaux P; Laatiri A; Zarrouk M; Bouaziz H; Harrabi I; Saad A
    Leuk Res; 2008 Dec; 32(12):1824-9. PubMed ID: 18556065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic study of myelodysplastic syndrome from India.
    Vundinti BR; Kerketta L; Jijina F; Ghosh K
    Indian J Med Res; 2009 Aug; 130(2):155-9. PubMed ID: 19797812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
    Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.
    Nisse C; Haguenoer JM; Grandbastien B; Preudhomme C; Fontaine B; Brillet JM; Lejeune R; Fenaux P
    Br J Haematol; 2001 Mar; 112(4):927-35. PubMed ID: 11298587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
    Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
    Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analysis of bone marrow from patients with primary myelodysplastic syndrome.
    Wu HK; Kitamura K; Xi YR; Wang YT; Liu SL; Zhou DB
    J Int Med Res; 1992 Jun; 20(3):254-66. PubMed ID: 1397670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.